MVIR:STO
Medivir AB
1,49 SEK
arrow_downward
-0,27%(-0,0040) 1D
12 հոկ, 14:36:43 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
1,49 SEK
High
1,51 SEK
Low
1,46 SEK
Mkt. cap
932,52 մլն
Avg. vol.
1,45 մլն
Volume
1,16 մլն
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 մլն
No. of employees
6
Open
1,49 SEK
High
1,51 SEK
Low
1,46 SEK
Mkt. cap
932,52 մլն
Avg. vol.
1,45 մլն
Volume
1,16 մլն
52-wk high
2,88 SEK
52-wk low
0,34 SEK
EPS
-0,37 SEK
Shares outstanding
624,18 մլն
No. of employees
6
News stories
From web sources and news partners
The Block
·
40 րոպե առաջ
Evernorth names former Coinbase investment exec to steer 473 million XRP treasury ahead of Nasdaq debut
Seeking Alpha
·
11 րոպե առաջ
Don't Be Afraid Of Midterms - Stay Bullish (NYSEARCA:SPY)
MarketBeat
·
19 րոպե առաջ
Carlsmed (NASDAQ:CARL) Price Target Raised to $24.00
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB